Michigan Medicine researchers determine that receptors inside heart cells could be targets for better beta blockers.
Kelly Malcom is the lead research communicator for Michigan Medicine. She promotes the work of the U-M basic science departments and the Institute for Healthcare Policy and Innovation via various channels. She has more than 15 years of experience in strategic communications, marketing, and health and science writing.
In a feat of biomedical engineering, researchers create model embryos that could be used to study the mysterious stages of early human development.
New research from Michigan Medicine could help clinicians identify which patients are more likely to continue to use opioids after surgery recovery.
A new mouse and human tissue study identifies an enzyme critical for normal wound healing
A study in rats has revealed the presence of naturally occurring DMT, an increasingly popular hallucinogen.